Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

194 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Golimumab reduces disease activity of rheumatoid arthritis for 1 year and strongly inhibits radiographic progression in Japanese patients: partial but detailed results of the GO-FORTH and GO-MONO studies.
Hayashi M, Kobayakawa T, Takanashi T, Yamazaki H, Ishikawa H, Kanamono T. Hayashi M, et al. Among authors: kobayakawa t. Clin Rheumatol. 2013 Jul;32(7):961-7. doi: 10.1007/s10067-013-2210-x. Epub 2013 Feb 10. Clin Rheumatol. 2013. PMID: 23397148 Clinical Trial.
A Fatal Case of Relapsing Pneumonia Caused by Legionella pneumophila in a Patient with Rheumatoid Arthritis After Two Injections of Adalimumab.
Hayashi M, Kuraishi H, Masubuchi T, Furihata K, Aida Y, Kobayakawa T, Deguchi M, Kojima T, Ishiguro N, Kanamono T. Hayashi M, et al. Among authors: kobayakawa t. Clin Med Insights Case Rep. 2013 Jun 12;6:101-6. doi: 10.4137/CCRep.S11641. Print 2013. Clin Med Insights Case Rep. 2013. PMID: 23843716 Free PMC article.
Drug retention rates of second biologic agents after switching from tumor necrosis factor inhibitors for rheumatoid arthritis in Japanese patients on low-dose methotrexate or without methotrexate.
Kobayakawa T, Kojima T, Takahashi N, Hayashi M, Yabe Y, Kaneko A, Shioura T, Saito K, Hirano Y, Kanayama Y, Miyake H, Asai N, Funahashi K, Hirabara S, Hanabayashi M, Asai S, Ishiguro N. Kobayakawa T, et al. Mod Rheumatol. 2015 Mar;25(2):251-6. doi: 10.3109/14397595.2014.953668. Epub 2014 Sep 11. Mod Rheumatol. 2015. PMID: 25211402
Discontinuation of concomitant methotrexate in Japanese patients with rheumatoid arthritis treated with tocilizumab: An interventional study.
Asai S, Hayashi M, Hanabayashi M, Kanayama Y, Takemoto T, Yabe Y, Shioura T, Ishikawa H, Yoshioka Y, Kato T, Hirano Y, Fujibayashi T, Hattori Y, Kobayakawa T, Ando M, Kuwatsuka Y, Takahashi N, Matsumoto T, Asai N, Sobue Y, Nishiume T, Suzuki M, Ishiguro N, Kojima T. Asai S, et al. Among authors: kobayakawa t. Mod Rheumatol. 2020 May;30(3):434-441. doi: 10.1080/14397595.2019.1641934. Epub 2019 Aug 7. Mod Rheumatol. 2020. PMID: 31390271 Clinical Trial.
Predictors of disease flare after discontinuation of concomitant methotrexate in Japanese patients with rheumatoid arthritis treated with tocilizumab.
Asai S, Takahashi N, Hayashi M, Hanabayashi M, Kanayama Y, Takemoto T, Yabe Y, Shioura T, Ishikawa H, Yoshioka Y, Kato T, Hirano Y, Fujibayashi T, Hattori Y, Kobayakawa T, Ando M, Kuwatsuka Y, Matsumoto T, Asai N, Sobue Y, Nishiume T, Suzuki M, Ishiguro N, Kojima T. Asai S, et al. Among authors: kobayakawa t. Joint Bone Spine. 2020 Dec;87(6):596-602. doi: 10.1016/j.jbspin.2020.06.001. Epub 2020 Jun 10. Joint Bone Spine. 2020. PMID: 32534200 Free article.
Predictors for clinical effectiveness of baricitinib in rheumatoid arthritis patients in routine clinical practice: data from a Japanese multicenter registry.
Takahashi N, Asai S, Kobayakawa T, Kaneko A, Watanabe T, Kato T, Nishiume T, Ishikawa H, Yoshioka Y, Kanayama Y, Watanabe T, Hirano Y, Hanabayashi M, Yabe Y, Yokota Y, Suzuki M, Sobue Y, Terabe K, Ishiguro N, Kojima T. Takahashi N, et al. Among authors: kobayakawa t. Sci Rep. 2020 Dec 14;10(1):21907. doi: 10.1038/s41598-020-78925-8. Sci Rep. 2020. PMID: 33318522 Free PMC article. Clinical Trial.
194 results